Aspen Neuroscience Inc. – Material Contracts Watch

EX-10.45

from S-1/A 4 pages Aspen Neurosciences, Inc. Equity Award Terms Amendment Agreement

12/34/56

EX-10.44

from S-1/A 27 pages Aspen Neuroscience, Inc. Stock Option Agreement

12/34/56

EX-10.12

from S-1/A 4 pages Aspen Neuroscience, Inc. Non-Employee Director Compensation Policy

12/34/56

EX-10.10

from S-1/A 19 pages Aspen Neuroscience, Inc. 2026 Employee Stock Purchase Plan

12/34/56

EX-10.5

from S-1/A 40 pages Aspen Neuroscience, Inc. 2026 Equity Incentive Plan

12/34/56

EX-10.43

from S-1 33 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** Main Services Agreement 1. Interpretation 1.1 the Following Definitions and Rules of Interpretation Apply in This Msa

12/34/56

EX-10.42

from S-1 15 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** Master Supply Agreement

12/34/56

EX-10.41

from S-1 43 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** Exclusive License Agreement Between the Cleveland Clinic Foundation and Aspen Neuroscience, Inc. Dated as of August 18, 2026 Exclusive License Agreement

12/34/56

EX-10.40

from S-1 8 pages Secured Convertible Promissory Note

12/34/56

EX-10.39

from S-1 24 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** Secured Convertible Promissory Note Purchase Agreement

12/34/56

EX-10.38

from S-1 9 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit***

12/34/56

EX-10.37

from S-1 54 pages Amended and Restated Collaboration and License Agreement Dated as of August 18, 2026 by and Between Aspen Neuroscience, Inc. and Cell X Technologies, Inc

12/34/56

EX-10.36

from S-1 5 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** Fourth Amendment to Collaboration and License Agreement

12/34/56

EX-10.35

from S-1 5 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** Third Amendment to Collaboration and License Agreement

12/34/56

EX-10.34

from S-1 5 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** Second Amendment to Collaboration and License Agreement

12/34/56

EX-10.33

from S-1 4 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** First Amendment to Collaboration and License Agreement

12/34/56

EX-10.32

from S-1 69 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** Collaboration and License Agreement Dated as of January 22, 2024 by and Between Aspen Neuroscience, Inc. and Cell X Technologies, Inc

12/34/56

EX-10.31

from S-1 22 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** License Agreement

12/34/56

EX-10.30

from S-1 30 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** Non-Exclusive License Agreement

12/34/56

EX-10.29

from S-1 16 pages ***Certain Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit*** Assignment and Assumption Agreement

12/34/56